How ICH E6 R3 is reshaping clinical trial oversight through risk-based approaches, Quality by Design, and stronger data governance.
Blog Of The Day
AURA: Revolutionizing Risk-Based Audit Planning in Pharmacovigilance
Discover how AURA is transforming audit planning process with automation, efficiency, and strategic innovation.
Restoring Clinical Trials: The Role of Data-Analytics Based Auditing in Rescue Studies
Contact us to explore how ADAMAS Data Analytics and early QA engagement can support your rescue study, from risk identification to regulatory resolution.
Navigating ICH E6(R3): A New Era for Clinical Trials
Understanding the transformative impact of ICH E6(R3) guidelines on clinical trial oversight and quality management.
Insights and Compliance Strategies for Pharmacovigilance Under the Windsor Framework
Understand key Windsor Framework changes for UK pharmacovigilance in 2025 and how MAHs can stay compliant under new MHRA rules
Computer Software Assurance (CSA): Why the Change and What Does it Mean?
The FDA’s new CSA guidance aims to streamline CSV by promoting risk-based validation, reducing documentation, and enhancing quality and patient safety.
Why Is Data Integrity Important When Transferring Data in a Clinical Trial?
Explore how a new validation model helps ensure data integrity in decentralized clinical trials, reducing compliance risk and enabling inspection readiness across complex systems.
Top 6 Tips for Inspection Readiness
Learn key strategies to ensure inspection readiness in clinical trials, from TMF accuracy to sponsor oversight, SME preparation, and quality-controlled documentation.
Superior Vendor Compliance Archiving
Discover how ADAMAS ensures long-term, inspection-ready access to audit records and documentation, supporting clients with reliable, compliant records retention.
The Rise of Decentralized Clinical Trials
Explore how decentralized clinical trials improve patient recruitment and retention through digital innovation—while a new validation model ensures data integrity, compliance, and inspection readiness.
Recent Posts
Clinical Quality Roundtable Series 2026 | USA
WEBINAR | “Designing Risk-Based QA Oversight for Clinical Trials Under ICH E6 (R3)”
Society of Quality Assurance (SQA) Annual Meeting 2026 | Maryland, USA
ICH E6 R3 — One Year On: From Regulatory Update to Operational Transformation
AURA: Revolutionizing Risk-Based Audit Planning in Pharmacovigilance